Hepatitis B core antibodies in Danish blood donors: a surrogate marker of risk behaviour
- 1 November 2001
- journal article
- research article
- Published by Wiley in Vox Sanguinis
- Vol. 81 (4) , 222-227
- https://doi.org/10.1046/j.0042-9007.2001.00113.x
Abstract
Background and Objectives The aim of this work was to determine the prevalence of antibodies to hepatitis B core antigen (anti‐HBc) among Danish blood donors and to correlate this with risk factors for blood‐borne and sexually transmitted diseases. Materials and Methods During a 5‐month period, 10 862 consecutive donors in the County of Funen were screened for anti‐HBc, and repeat‐reactive samples were confirmed by supplementary testing. Information on risk factors was assessed by questionnaire in 585 consecutive anti‐HBc‐negative blood donors and compared with information obtained from confirmed positive donors. Results The prevalence of confirmed positive anti‐HBc among donors was 0·70% (76/10 862, 95% confidence interval [CI]: 0·55–0·87). One donor was positive for anti‐HBc immunoglobulin M (IgM); none tested positive for hepatitis B virus (HBV) DNA. In a logistic regression analysis, age, female gender, tattoos and commercial sexual relations, were independent predictive factors for the presence of anti‐HBc. Conclusion Anti‐HBc is a surrogate marker for previous risk behaviour in the Danish blood donor population. We suggest that screening for anti‐HBc may be used among new donors to supplement interviews on risk behaviour.Keywords
This publication has 19 references indexed in Scilit:
- Risk Factors and Anti‐HBc Reactivity among First Time Blood DonorsVox Sanguinis, 1997
- Does Anti-HBc Reactivity Reflect 'Lifestyle' Risk in North London Blood Donors?Vox Sanguinis, 1997
- Feasibility and usefulness of an efficient anti‐HBc screening programme in blood donorsTransfusion Medicine, 1995
- Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipientsTransfusion, 1995
- Heterosexually acquired human immunodeficiency virus infection and the United States blood supply: considerations for screening of potential blood donorsTransfusion, 1993
- Significance of antibody to hepatitis B core antigen in blood donors as determined by their serologic response to hepatitis B vaccineTransfusion, 1993
- Isolated antibody to hepatitis B core antigen in blood donors and immune response to hepatitis B vaccinationAustralian and New Zealand Journal of Medicine, 1993
- Absence of hepatitis B virus DNA detected by polymerase chain reaction in blood donors who are hepatitis B surface antigen negative and antibody to hepatitis B core antigen positive from a United States population with a low prevalence of hepatitis B serologic markersTransfusion, 1993
- Antibodies to hepatitis B core antigen and the infectivity of the blood supply. Scientific Section Coordinating CommitteeTransfusion, 1991
- Diagnosis of Acute and Inapparent Hepatitis B Virus Infections by Measurement of IgM Antibody to Hepatitis B Core AntigenThe Journal of Infectious Diseases, 1980